Pioneering new therapies for cancer

LATEST NEWS

Presentation at Oppenheimer Healthcare Conference
Webcast | Slides


Second Quarter Fiscal Year 2017 Results
Press Release


Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (ASH)
Press Release | Presentation


Formulation Selection and Development for ME-401 (AAPS)
Poster